ADHD: An Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder Adults with Attention-Deficit/Hyperactivity Disorder
Source: ADHD Clinical Trials at Partners Healthcare Massachusetts - Category: Psychiatry Source Type: clinical trials
More News: ADHD | Autism | Clinical Trials | Concerta | Hyperactivity | Methylphenidate | Psychiatry | Ritalin